22.2 C
New York
Tuesday, July 22, 2025

Tag: role

newssourceFORcompanycontentinformation1markettime

Envision Energy Contracted to Deliver Two 100 MWh Battery Energy Storage Projects for Field in Scotland

EDINBURGH, Scotland, July 22, 2025 /PRNewswire/ -- Envision Energy, a global leader in green technology, announced today that it has executed two supply agreements to...

Envision Energy Contracted to Deliver Two 100 MWh Battery Energy Storage Projects for Field in Scotland

EDINBURGH, Scotland, July 22, 2025 /PRNewswire/ -- Envision Energy, a global leader in green technology, announced today that it has executed two supply agreements to...

IIHM Reveals First-Ever Hospitality AI Awards, Hosts Landmark Debate on Tech & Human Touch

KOLKATA, India, July 22, 2025 /PRNewswire/ -- The International Institute of Hotel Management (IIHM), India's most internationally recognized hospitality education brand, marked World AI...

SNACKS, PEP TALKS, AND SECRET CRIES: SURVEY REVEALS WHAT AUSTRALIANS REALLY DO IN THEIR CARS

BRISBANE, Australia, July 22, 2025 /PRNewswire/ -- New research released today from insurance provider Youi has revealed that for many Australians, their car is...

Accounting Automation Tools (2025): QuickBooks Awarded Best Accounting Automation Solution in Report by Better Business Advice

NEW YORK, July 22, 2025 /PRNewswire/ -- Better Business Advice has named QuickBooks the Best Accounting Automation Solution of 2025, citing its significant advancements in...

Bitget Expands Starlink-Powered PayFi Islands Initiative to Negros Oriental

Bitget brings Starlink internet to schools and creative hubs in Negros Oriental, accelerating digital inclusion and Web3 access.

Wynn Inaugurates Special Exhibition “The Odyssey of Jingdezhen Porcelain: A Heritage Voyage from Macao to the World”

MACAU, July 22, 2025 /PRNewswire/ -- In July's high summer season, the "Art Macao: Macao International Art Biennale 2025" has kicked off and the Special...

Precision Era to Redefine Treatment, Drive $450B Economic Investment and Change Lives Across Asia Pacific

SINGAPORE, July 22, 2025 /PRNewswire/ -- The Precision Era of medicine is arriving in Asia Pacific, driven by the arrival of a critical mass...

Mitrade Trading Platform Partners with Argentine Football Association as Football Fever Sweeps APAC

TAIPEI, July 22, 2025 /PRNewswire/ -- As Argentina's national team jerseys continue to outsell traditional football powerhouses across Southeast Asia and Australia, Mitrade, a global...

Ballard announces order for 6.4 MW to eCap Marine for Samskip vessels

VANCOUVER, BC, July 22, 2025 /PRNewswire/ -- Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced the signing of a new purchase order for...

Ballard announces order for 6.4 MW to eCap Marine for Samskip vessels

VANCOUVER, BC, July 21, 2025 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced the signing of a new purchase order for the...

Ballard announces order for 6.4 MW to eCap Marine for Samskip vessels

VANCOUVER, BC, July 21, 2025 /CNW/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced the signing of a new purchase order for the...

Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International Conference (AAIC), taking place July 27-31 in Toronto, Canada. Data on LEQEMBI® (lecanemab) will include 48-month results from the Clarity AD open-label extension, real-world evidence, and new insights into a subcutaneous formulation for maintenance dosing. Presentations on tau will explore tau-targeted therapies and biomarkers, including baseline characteristics of participants from CELIA, a Phase 2 trial evaluating the efficacy, safety, and tolerability of BIIB080, an investigational antisense oligonucleotide (ASO) therapy that targets tau.

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRole

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers